ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
80,600
+2,800 (3.60%)
May 30, 2025, 3:30 PM KST

ABL Bio Revenue

ABL Bio had revenue of 2.16B KRW in the quarter ending March 31, 2025, a decrease of -72.73%. This brings the company's revenue in the last twelve months to 27.63B, down -16.53% year-over-year. In the year 2024, ABL Bio had annual revenue of 33.40B, down -49.04%.

Revenue (ttm)
27.63B
Revenue Growth
-16.53%
P/S Ratio
141.56
Revenue / Employee
270.89M
Employees
102
Market Cap
3,911.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202433.40B-32.14B-49.04%
Dec 31, 202365.55B-1.75B-2.61%
Dec 31, 202267.30B61.97B1,162.19%
Dec 31, 20215.33B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition